Tenaya Therapeutics, Inc. Investment Income, Interest
Tenaya Therapeutics, Inc. (TNYA) reported Investment Income, Interest of $697.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-05
- Tenaya Therapeutics, Inc. investment income, interest for the quarter ending 2026-06-30 was $697.00K, a 14.48% decline year-over-year.
- Tenaya Therapeutics, Inc. investment income, interest for the quarter ending 2026-03-31 was $793.00K, a 24.88% increase year-over-year.
- Tenaya Therapeutics, Inc. investment income, interest for the quarter ending 2025-12-31 was $575.00K, a 29.19% decline year-over-year.
- Tenaya Therapeutics, Inc. investment income, interest for the quarter ending 2025-09-30 was $658.00K, a 39.07% decline year-over-year.
- Tenaya Therapeutics, Inc. investment income, interest for fiscal 2025 was $2.68M, a 43.38% decline from fiscal 2024.
- Tenaya Therapeutics, Inc. investment income, interest for fiscal 2024 was $4.74M, a 32.87% decline from fiscal 2023.
- Tenaya Therapeutics, Inc. investment income, interest for fiscal 2023 was $7.06M, a 261.11% increase from fiscal 2022.
- Tenaya Therapeutics, Inc. investment income, interest for fiscal 2022 was $1.95M, a 1709.26% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $697.00K 10-Q · filed 2026-08-05 | $1.49M 10-Q · filed 2026-08-05 | $2.06M derived: sum of 3 quarters · filed 2026-08-05 | $2.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $793.00K 10-Q · filed 2026-05-06 | $1.37M derived: sum of 2 quarters · filed 2026-05-06 | $2.03M derived: sum of 3 quarters · filed 2026-05-06 | $2.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.23M derived: sum of 2 quarters · filed 2026-03-11 | $2.05M derived: sum of 3 quarters · filed 2026-08-05 | $2.68M 10-K · filed 2026-03-11 |
| 2025-09-30 | $658.00K 10-Q · filed 2025-11-10 | $1.47M derived: sum of 2 quarters · filed 2026-08-05 | $2.11M 10-Q · filed 2025-11-10 | $2.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $815.00K 10-Q · filed 2026-08-05 | $1.45M 10-Q · filed 2026-08-05 | $2.26M derived: sum of 3 quarters · filed 2026-08-05 | $3.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $635.00K 10-Q · filed 2026-05-06 | $1.45M derived: sum of 2 quarters · filed 2026-05-06 | $2.53M derived: sum of 3 quarters · filed 2026-05-06 | $3.92M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $812.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.89M derived: sum of 2 quarters · filed 2026-03-11 | $3.29M derived: sum of 3 quarters · filed 2026-03-11 | $4.74M 10-K · filed 2026-03-11 |
| 2024-09-30 | $1.08M 10-Q · filed 2025-11-10 | $2.47M derived: sum of 2 quarters · filed 2025-11-10 | $3.92M 10-Q · filed 2025-11-10 | $5.39M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $1.39M 10-Q · filed 2025-08-06 | $2.85M 10-Q · filed 2025-08-06 | $4.32M derived: sum of 3 quarters · filed 2025-08-06 | $6.09M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $1.45M 10-Q · filed 2025-05-07 | $2.92M derived: sum of 2 quarters · filed 2025-05-07 | $4.70M derived: sum of 3 quarters · filed 2025-05-07 | $6.54M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $3.25M derived: sum of 2 quarters · filed 2025-03-10 | $5.08M derived: sum of 3 quarters · filed 2025-03-10 | $7.06M 10-K · filed 2025-03-10 |
| 2023-09-30 | $1.78M 10-Q · filed 2024-11-06 | $3.61M derived: sum of 2 quarters · filed 2024-11-06 | $5.59M 10-Q · filed 2024-11-06 | $6.62M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $1.84M 10-Q · filed 2024-08-08 | $3.81M 10-Q · filed 2024-08-08 | $4.85M derived: sum of 3 quarters · filed 2024-08-08 | $5.44M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.97M 10-Q · filed 2024-05-14 | $3.01M derived: sum of 2 quarters · filed 2024-05-14 | $3.61M derived: sum of 3 quarters · filed 2024-05-14 | $3.83M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $1.63M derived: sum of 2 quarters · filed 2024-03-18 | $1.85M derived: sum of 3 quarters · filed 2024-03-18 | $1.95M 10-K · filed 2024-03-18 |
| 2022-09-30 | $596.00K 10-Q · filed 2023-11-08 | $818.00K derived: sum of 2 quarters · filed 2023-11-08 | $917.00K 10-Q · filed 2023-11-08 | $984.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $222.00K 10-Q · filed 2023-08-09 | $321.00K 10-Q · filed 2023-08-09 | $388.00K derived: sum of 3 quarters · filed 2023-08-09 | $411.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $99.00K 10-Q · filed 2023-05-10 | $166.00K derived: sum of 2 quarters · filed 2023-05-10 | $189.00K derived: sum of 3 quarters · filed 2023-05-10 | $198.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $90.00K derived: sum of 2 quarters · filed 2023-03-08 | $99.00K derived: sum of 3 quarters · filed 2023-03-08 | $108.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $23.00K 10-Q · filed 2022-11-10 | $32.00K derived: sum of 2 quarters · filed 2022-11-10 | $41.00K 10-Q · filed 2022-11-10 | $46.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $9.00K 10-Q · filed 2022-08-10 | $18.00K 10-Q · filed 2022-08-10 | $23.00K derived: sum of 3 quarters · filed 2022-08-10 | $30.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $9.00K 10-Q · filed 2022-05-11 | $14.00K derived: sum of 2 quarters · filed 2022-05-11 | $21.00K derived: sum of 3 quarters · filed 2022-05-11 | $39.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $12.00K derived: sum of 2 quarters · filed 2022-03-23 | $30.00K derived: sum of 3 quarters · filed 2022-03-23 | $87.00K 10-K · filed 2022-03-23 |
| 2020-09-30 | $7.00K 10-Q · filed 2021-11-10 | $25.00K derived: sum of 2 quarters · filed 2021-11-10 | $82.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $18.00K 10-Q · filed 2021-09-08 | $75.00K 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |